Contact this trialFirst, we need to learn more about you.
PET/CT Scan with Tracers for Prostate Cancer
Recruiting3 awardsPhase 2
Atlanta, Georgia
This trial is studying whether a PET/CT scan using fluciclovine F18 or 68Ga-PSMA is better at planning radiation treatments and enhancing outcomes in patients with prostate adenocarcinoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service